Received: 25 September 2020
Accepted: 18 December 2020
First Online: 11 January 2021
Ethic approval and consent to participate
: This study was approved by our local Institutional Review Board (Comité de Protection des Personnes Nord Ouest IV IORG0009553, validation no HP 20/40). In accordance with the French law, and because of the retrospective observational design, written informed consent was not required.
: Not applicable.
: SN: MSD (advisory board and lecture); Pfizer, Gilead, and Biomérieux (lecture). Other authors: none.